[1] Cheng ZJ, Shan J.2019 Novel coronavirus: where we are and what we know[J]. Infection, 2020, 48(2):155-163. [2] 严珺, 尹文, 张侃.新型冠状病毒(SARS-CoV-2)对血液安全的影响[J/OL].临床输血与检验:1-7(2020-03-12).http://kns.cnki.net/kcms/detail/34.1239.R.20200312.1054.002.html. [3] 王世春, 阮潜瑛, 刁荣华, 等.COVID-19流行期间采供血工作特点及对策[J/OL].临床输血与检验:1-5(2020-03-23).http://kns.cnki.net/kcms/detail/34.1239.r.20200320.1916.002.html. [4] 中国输血协会. 关于新型冠状病毒疫情防控期间采供血工作的若干工作建议(第一版)[EB/OL]. (2020-02-05).http://www.csbt.org.cn/plus/view.php?aid=16530. [5] 重庆市人民政府.重庆启动重大突发公共卫生事件I级响应[EB/OL].(2020-01-24).http://cq.cqnews.net/html/2020-01/24/content_50787157.html. [6] 中华人民共和国国家卫生和计划生育委员会. 献血相关血管迷走神经反应预防和处置指南[S].WS/T 595-2018. [7] Neustadter JH, Samarin F, Carlson KR, et al.Extracorporeal photochemotherapy for generalizeddeep morphea[J].Arch Dermatol, 2009, 145(2):127-130. [8] 中国输血协会.T/CSBT 001-2019血液安全监测指南[S].2019. [9] Fisher SA, Allen D, Dorée C, et al.Interventions to reduce vasovagal reactions in blood donors:a systematic review and meta-analysis[J].Transfus Med, 2016, 26(1):15-33. [10] Morand C, Coudurier N, Rolland C, et al.Prevention of syncopal-type reactions after whole blood donation:a cluster-randomized trial assessing hydration and muscle tension exercise[J]. Transfusion, 2016, 56(10):2412-2421. [11] Lee HP, Wang DY.Objective assessment of increase in breathing resistance of N95 respirators on human subjects[J]. Ann Occup Hyg, 2011, 55(8):917-921. [12] Eder AF, Hillyer CD, Dy B A, et al.Adverse reactions to allogeneic whole blood donation by 16- and 17-year-olds[J]. JAMA, 2008, 299(19):2279-2286. [13] Kamel H, Tomasulo P, Bravo M, et al.Delayed adverse reactions to blood donation[J]. Transfusion, 2010, 50(3):556-565. [14] 张涛, 刘健娣, 范亚欣. 献血量占总血容量比率与血管迷走神经反应关系的研究[J]. 临床血液学杂志(输血与检验), 2018, 31(5):784-787. [15] 孙蕴华, 马庆, 向东, 等. 采血不足量原因分析及控制措施[J]. 中国输血杂志, 2017, 30(7):770-772. [16] Custer B, Rios J A, Schlumpf K, et al.Adverse reactions and other factors that impact subsequent blood donation visits[J]. Transfusion, 2012, 52(1):118-126. [17] Goldman M, Land K, Robillard P, et al.Development of standard definitions for surveillance of complications related to blood donation[J].Vox Sang, 2016, 110(2):185-188. [18] Wiersum-Osselton JC, Marijt-van der Kreek TM V, Bokhorst AG, et al. Donor vigilance:a global update[J]. ISBT Sci Ser, 2014, 9(1):228-233. |